GlassScriptPhysician profile
Edward Mccarron
NPI 1205805744
$8,316.26
in general payments reported to CMS, 2019-2025
8 companies · $29.91 in 2025
The $29.91 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,138 · 2022: $935 · 2023: $1,001 · 2024: $213 · 2025: $29.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $847 · Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $847.28 |
| Food and Beverage | $396.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,915.64 | 2021-2024 | Da Vinci Surgical System |
| Boston Scientific Corporation | $148.22 | 2024 | Cre Pro, Spyglass Discover |
| Integra Lifesciences Corporation | $76.19 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ethicon US, LLC | $71.79 | 2023 | Enseal, Stratafix |
| Regeneron Healthcare Solutions, INC. | $31.56 | 2023 | Libtayo |
| Conmed Corporation | $29.91 | 2025 | Airseal |
| Kerecis Limited | $22.62 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| E.R. Squibb & Sons, L.L.C. | $20.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Mccarron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.